Strong Q3 earnings beat on both EPS and revenue, broad organic growth across all segments (11.7%), record sales in all three business segments, improved margins, strong free cash flow conversion (144%), debt reduction, raised full-year guidance, and Zacks Rank #2 (Buy) with upward estimate revisions. The 6.9% stock decline appears to be a temporary pullback despite fundamentally strong results.
NDSN has a solid Zacks Rank #2 (Buy) indicating positive earnings outlook, but its valuation metrics are less attractive compared to MWA, with a higher forward P/E (26.14), higher PEG ratio (2.01), higher P/B ratio (5.27), and a poor Value grade (F), making it less suitable for value-focused investors.
Company demonstrated shareholder-friendly capital allocation with a 15% dividend increase and 63-year dividend growth streak. Strong cash flows and segment performance in Medical and Industrial solutions support positive outlook, though offset somewhat by high debt concerns.
NDSN has a lower Zacks Rank #3 (Hold), a Value grade of D, and less attractive valuation metrics with a higher forward P/E and PEG ratio, indicating it is less favorably positioned as a value investment compared to MWA.
Articles that tag NDSN but are mainly about other companies.
Consistently beats earnings estimates with 2.6% average surprise over trailing four quarters and recent consensus estimate increases of 2.1% for fiscal 2026. Carries Zacks Rank #2 (Buy).
Growing demand for nonwoven and industrial coating products drives the Industrial Precision Solutions segment, but high costs remain a significant concern.
Diversified business structure mitigates market weakness, consistent acquisition strategy, 15.6% YoY earnings growth expected, 32.4% average trailing four-quarter earnings surprise, Zacks Rank #2 (Buy)
Nordson's PICO Nex system couples servo jets with predictive analytics and the company acquired Atrion for USD 800 million, indicating strategic expansion and technological advancement in the syringe filling market.
Attractive dividend growth story with 13% annualized dividend growth over the past decade. Dividend yield near 10-year highs at 1.1%. Valuation metrics mixed but reasonable, appealing to growth and dividend income investors.
Articles and sentiment ratings from Massive / Polygon. Sentiment is the provider's model rating for this company, not Gainbot's view.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology
